Table 4. Analysis of PSA levels of prostate cancer patients and histopathological characteristics of the tumors.
Parameters | Categories | N | % |
---|---|---|---|
PSA level | 0.0 - 4.0 | 10 | 3.7 |
(ng/mL) | 4.1 - 10.0 | 147 | 54.0 |
> 10.1 | 115 | 42.3 | |
Total* | 272 | 100.0 | |
Gleason Score | 3-6 | 133 | 48.4 |
7 | 117 | 42.5 | |
8-10 | 25 | 9.1 | |
Total* | 275 | 100.0 | |
Extracapsular extension | Presence | 97 | 37.7 |
Absence | 160 | 62.3 | |
Total* | 257 | 100.0 | |
Seminal vesicle invasion | Presence | 32 | 12.5 |
Absence | 225 | 87.5 | |
Total* | 257 | 100.0 | |
Perineural invasion | Presence | 42 | 16.3 |
Absence | 215 | 83.7 | |
Total* | 257 | 100.0 | |
Bilaterality | Presence | 137 | 53.1 |
Absence | 121 | 46.9 | |
Total* | 258 | 100.0 | |
Lymphatic invasion | Presence | 6 | 2.5 |
Absence | 232 | 97.5 | |
Total* | 238 | 100.0 | |
TNM Staging | T2 | 154 | 60.4 |
T3 and T4 | 101 | 39.6 | |
Total* | 255 | 100.0 |
It was not possible to evaluate the parameters for all 277 patients.